Frank Cheng

CEO, Caristo Diagnostics

[Frank Cheng @fcheng317]

Great to see that JAMA Network Open tweet on @EyenukInc pivotal trial results for #EyeArt (96% sensitivity for detection of more than mild diabetic retinopathy, and 97% sensitivity for vision-threatening diabetic retinopathy).

https://t.co/jKs1ZecaYE

[JAMA Network Open @JAMANetworkOpen]

In this diagnostic study, the EyeArt autonomous AI system showed high sensitivity and specificity for detecting #DiabeticRetinopathy versus the reference standard. @EyenukInc https://t.co/ZaKunQJxeE

[Frank Cheng @fcheng317]

Check out my latest article: Eyenuk Applauds CMS CY 2022 Medicare Physician Fee Schedule Final Rule to Establish National Price for Autonomous AI Technology https://t.co/dI7X8nuc5U via @LinkedIn

[Frank Cheng @fcheng317]

@EyenukInc is excited to work with several top diabetes centers in Germany, all listed among the top 50 hospitals in the world for Best Specialized Hospitals for Endocrinology.
#diabetes #diabeticretinopathy #eyeart #artificialintelligence

https://t.co/F67KdFXsBA

[Eyenuk, Inc. @EyenukInc]

Top German Diabetes Centers, including @HdzNrw , Diabetes Center Mergentheim, and @uni_tue Hospital adopt @EyenukInc #AI Technology. #diabeticretinopathy #diabetescare #artificialintelligence #telemedicine #EyeArt https://t.co/OF6MsWWfCV

[Frank Cheng @fcheng317]

Nice article based on #EyeArt UK study published by @BMJ_Ophth.
#artificialintelligence #diabeticretinopathy #nhsuk
https://t.co/T9deSGKZX3

[Frank Cheng @fcheng317]

Closing #HEDIS measurement gaps is important for all #healthplans. @EyenukInc is excited to partner with HCD International to support health plans with AI solutions for #diabetes eye testing.

#NCQA #fivestars #artificialintelligence #92229

https://t.co/lNGrlH4pwf

[Eyenuk, Inc. @EyenukInc]

@HCDI_Inc adopts @EyenukInc #AI technology to close #HEDIS gaps for health plans:
https://t.co/MwHvM1A7N9
#EyeArt #artificialintelligence #diabetescare #diabeticretinopathy

[Frank Cheng @fcheng317]

@FredHollows is one of the most reputable non-profit aid organizations around the world. It is a true honor for @EyenukInc AI technology to be chosen for #diabeticretinopathy testing in hospitals in #Vietnam.
https://t.co/dmuqMNYcWk

[Eyenuk, Inc. @EyenukInc]

@EyenukInc #AI Technology Selected for Diabetic Eye Testing in Vietnam Supported by @FredHollows. https://t.co/DYs2V6e1xT
#diabeticretinopathy #diabetescare #artificialintelligence #EyeArt

[Frank Cheng @fcheng317]

Welcome new investors led by @AXAIMAlts to the Eyenuk, Inc. team! Exciting growth is ahead of us.

https://t.co/b51sV7s2bJ

[Eyenuk, Inc. @EyenukInc]

We are excited to announce a $6.2M financing led by @AXAIM Impact Investing strategy and look forward to working with @AXAIMAlts and Global Health Investment Advisors. https://t.co/lnQK79j1kP

#impactinvesting #venturecapital #AI #digitalhealth #diabeticretinopathy #ophthalmology

[Frank Cheng @fcheng317]

Excited to moderate the webinar today with @aao_ophth experts to highlight latest reimbursement status for CPT 92229, the first #CPT code for an autonomous #AI technology. #Medicare, #Medicaid, and #HEDIS payment status will be discussed.
https://t.co/JPTD5ZKG7g

[Eyenuk, Inc. @EyenukInc]

Join us on 6/29 at 5p ET for a review and update on reimbursement for automated AI interpretation of diabetic eye exams. Register here https://t.co/6DWfT7g9Zd
#artificialintelligence #diabeticretinopathy #medicare #medicaid #CPT92229 #aao2021 #asrs2021 #aoa2021 #retina

[Frank Cheng @fcheng317]

Visit @EyenukInc virtual booth at #ADA2021 during June 25-29.

https://t.co/xEwZPW53Fw

[Eyenuk, Inc. @EyenukInc]

We are excited to participate in the @AmDiabetesAssn81st Scientific Sessions! Visit our virtual booth to learn more about our EyeArt AI system for automated diabetic retinopathy testing. #ADA2021 #diabetes #diabeticretinopathy #AI #EyeArt

[Frank Cheng @fcheng317]

Look forward to panel discussion on Medicare/Medicaid reimbursement status for CPT 92229. Panel will include David B. Glasser, Michael X. Repka, and Kayla L. Amodeo from the American Academy of Ophthalmology, as well as Michael Beebe from ADVI Health.

https://t.co/JPTD5ZKG7g

[Eyenuk, Inc. @EyenukInc]

Join us on 6/29 at 5p ET for a review and update on reimbursement for automated AI interpretation of diabetic eye exams. Register here https://t.co/6DWfT7g9Zd
#artificialintelligence #diabeticretinopathy #medicare #medicaid #CPT92229 #aao2021 #asrs2021 #aoa2021 #retina

[Frank Cheng @fcheng317]

Join this interesting webinar tomorrow to learn how @WorldDiabetesF funding and @EyenukInc AI technology significantly improved access to eye care in Armenia's low resource areas.

https://t.co/JbJjaGV1VW

[Eyenuk, Inc. @EyenukInc]

Join us tomorrow, Tuesday June 8th at 11a ET for a #webinar event featuring the @ArmenianEyeCare Project and learn about and learn about how #AI empowers community based eye screening in low resource areas. Register here: https://t.co/K8MxWaAVpi
#diabeticretinopathy #AI #EyeArt

[Frank Cheng @fcheng317]

@ArmenianEyeCare webinar should be very informative. The national screening initiative leverages #EyeArt AI technology from @EyenukInc and earned recognition by both @WorldDiabetesF and @WHO.

https://t.co/CodZbdChNP

[Frank Cheng @fcheng317]

Join this afternoon's webinar and learn how a private retina specialist practice grows business by leveraging FDA cleared AI technology in community eye screening.

#retinaspecialist #ophthalmology #HEDIS #diabeticretinopathy #diabetes #optometry

https://t.co/HBl6EIpBJB

[Eyenuk, Inc. @EyenukInc]

Join us TODAY at 5p ET for a #webinar event featuring @WagnerRetina and learn about innovative strategies for community eye screening. Register here: https://t.co/NYFhjdoE2t
#diabeticretinopathy #AI #EyeArt

[Frank Cheng @fcheng317]

Really looking forward to this webinar! Wagner Macula and Retina Center is not only a thought-leading group for retina disease management, but also a national leader for community eye screening.
https://t.co/LEyyM9CuvF

[Eyenuk, Inc. @EyenukInc]

Join us on 5/20 at 5p ET for a #webinar event featuring @WagnerRetina and learn about innovative strategies for community eye screening. Register here: https://t.co/NYFhjdoE2t
#diabeticretinopathy #AI #EyeArt

[Frank Cheng @fcheng317]

Insightful article by A. Paul Chous, MA, OD, FAAO
https://t.co/iiQtZi8K76

[Frank Cheng @fcheng317]

Congratulations to Eyenuk, Inc. clinical collaborators for a great presentation "Community Based eye screening by Armenian EyeCare Project".
https://t.co/YQIfEzs5Ay

#artificialintelligence #diabetes #diabeticretinopathy @ArmenianEyeCare

[Frank Cheng @fcheng317]

Eyenuk, Inc. is honored to be featured on NIH's website today as a national success story! NIH supported and guided us since day 1, which greatly fueled our continuous innovation.

https://t.co/nLrzQPIdVF

[Frank Cheng @fcheng317]

Welcome the newest customer for the EyeArt AI diabetic eye testing system... the University Hospital of New Jersey in Newark at its Emergency Department!

https://t.co/VAuXMcfxYe

[Eyenuk, Inc. @EyenukInc]

@Rutgers_NJMS implements the #EyeArt system in its teleophthalmology program for emergency department based diabetic eye screening. #AI #diabetescare #diabeticretinopathy #emergencymedicine
https://t.co/2UdKJhURaY

[Frank Cheng @fcheng317]

Very comprehensive review of AI in retina by Dr. Grayson Armstrong, a physician and surgeon at Massachusetts Eye and Ear and an instructor in ophthalmology at Harvard Medical School, Boston.

https://t.co/yMe1OLUiu4

[Eyenuk, Inc. @EyenukInc]

@RetSpecMag highlights #EyeArt system and suggests #artificialintelligence is ready for use in #retinaspecialist referral networks. #diabeticretinopathy #diabetescare #AI #retina
https://t.co/dk5YdtrnE1

[Frank Cheng @fcheng317]

We are glad that our FDA cleared and Medicare reimbursed #EyeArt AI system is contributing to healthcare access equality, as a free and charitable care clinic in Virginia chooses EyeArt to support its diabetic eye testing.

https://t.co/j77U2H84GT

[Eyenuk, Inc. @EyenukInc]

@SinclairClinicbecomes the first free and charitable health clinic to adopt the #EyeArt #AI system for diabetic eye screening. Read more here: https://t.co/Syd2PVRNV8
#diabeticretinopathy #diabetescare #communityhealth #artificialintelligence